leupeptin has been researched along with Lymphoma, B-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corradin, G; Escobar, P; Healy, F; Mach, JP; Valmori, D; Yu, Z | 1 |
| Goldenberg, DM; Lu, HH; Shih, LB; Xuan, H | 1 |
| Chiocchia, G; Fournier, C; Lotteau, V; Manoury-Schwartz, B | 1 |
3 other study(ies) available for leupeptin and Lymphoma, B-Cell
| Article | Year |
|---|---|
Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells.
Topics: Amino Acid Sequence; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Chloroquine; Histocompatibility Antigens Class II; Humans; Immunoglobulin Light Chains; Immunotoxins; Leupeptins; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Peptides; Tetanus Toxin | 1994 |
Internalization and intracellular processing of an anti-B-cell lymphoma monoclonal antibody, LL2.
Topics: 4-Chloro-7-nitrobenzofurazan; Ammonium Chloride; Antibodies, Monoclonal; Burkitt Lymphoma; Ceramides; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Golgi Apparatus; Humans; Immunoglobulin Fab Fragments; Kinetics; Leupeptins; Lymphoma, B-Cell; Lysosomes; Microscopy, Fluorescence; Tumor Cells, Cultured | 1994 |
Selective increased presentation of type II collagen by leupeptin.
Topics: Animals; Antigen Presentation; Antigen-Presenting Cells; Antigens, Differentiation, B-Lymphocyte; Brefeldin A; Collagen; Cyclopentanes; Dimerization; Epitopes; Histocompatibility Antigens Class II; Immunophenotyping; Leupeptins; Lymphoma, B-Cell; Mice; Mice, Inbred DBA; Protease Inhibitors; Protein Synthesis Inhibitors; Sodium Dodecyl Sulfate; Tumor Cells, Cultured | 1997 |